Randomized controlled trialHuman

Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial

Archives of neurology, 2012 Nov. Baker LD, Barsness SM, Borson S and 4 others.

Study type
Randomized controlled trial
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Archives of neurology
Published
2012 Nov
PubMed
PMID 22869065 ↗
DOI
10.1001/archneurol.2012.1970 ↗
Full text
Free on PubMed Central (PMC3764914) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Sermorelin →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Absorptiometry, PhotonAffectAgedAged, 80 and overBody CompositionCase-Control StudiesCognitive DysfunctionDouble-Blind MethodExecutive FunctionFemaleFollow-Up StudiesGlucose Tolerance Test

Other papers on Sermorelin

Journal article · 2006
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Journal article · 1999
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds